The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation from Dr. Yair Lotan ...

The immune checkpoint inhibitor combination regimen has become the initial standard of care for metastatic RCC, given its ...

Table 1. Metric comparison between robotic and laparoscopic donor nephrectomy approaches.

In a real-world, multi-center cohort, patients receiving LHRH agonists as compared to LHRH antagonists were found to be at ...

Moderated by Dr. Thomas Chi (UAB), the panel featured Dr. Vernon Pais (Dartmouth), Dr. Karen Stern (Mayo Clinic Arizona), Dr.

Dr. Valdes concluded this presentation discussing whether artificial intelligence can match multidisciplinary expertise in managing high and very high risk prostate cancer with positive surgical ...

These results suggest that anti-CTLA4 ICI synergizes with the Ad-PS2 vaccine to generate a robust cytotoxic T-cell response capable of inducing both primary tumor clearance and long-term resistance, ...

Detalimogene voraplasmid is a novel, investigational, non-integrating, non-viral genetic medicine-based immunotherapy carrying a plasmid that simultaneously expresses IL-12 and regulators of RIG-I.

On the other hand, radium-223 dichloride is an alpha particle-emitting calcium mimetic that selectively targets bone metastases and induces double-stranded DNA breaks. In the ALSYMPCA trial, ...

On the third day of the annual World Congress of Endourology and Uro-Technology Meeting, Dr. Ahmed Ghazi, MD, MS of Johns Hopkins University delivered a State-of-the-Art Lecture Plenary on 3D printing ...

This was a descriptive, observational, and retrospective study of patients who underwent radical prostatectomy and PSMA PET/CT for staging between October 2019 and May 2024. The objective of the study ...

The 2025 South Central AUA annual meeting included a session on kidney cancer, featuring a presentation from Dr. Vedant Agrawal discussing patient-reported barriers, social determinants, and racial ...